A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

while the inhibition of α-cell secretion has received less attention. The aim of this research was to quantify the glucagonostatic contribution to the glucose-lowering effect of GLP-1 infusions ...

As former “Health and Wellness” columnist Sharon Gerdes wrote in her September column, one such ingredient that could be beneficial is Palatinose, Beneo’s patented isomaultulose, which can be used in ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

MBX Biosciences, Inc. (MBX) announced Tuesday positive results from its Phase 1 single ascending dose or SAD and multiple ascending ...

In the MAD cohort, MBX 1416 appeared to increase GLP-1 within 60 minutes of a mixed meal tolerance test, suggesting a ...

KEEN to lose weight in 2025? So are almost half of our readers. While weight-loss jabs, similar to Ozempic, boomed in ...

The "Semaglutides Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This Semaglutides market report covers market characteristics, size and growth, segmentation, regional ...

GLP-1 is a hormone secreted from the intestines after meals that promotes insulin secretion and suppresses appetite. The ...

From foods that mimic the effects of Ozempic to energy-boosting injectables, these are the emerging health trends that will ...